Thread by @PrasadWakchaure

#IOLCP List of products

APIs in market: Ibuprofen, Metformin, Clopidogrel, Fenofibrate, Lamotrigine & Ursodeoxycholic
Acid

APIs in the pipeline: Pantoprazole, Gabapentin, Losartan, Domperidone, Fexofenadine, Pregabalin, Quetiapine

Chemicals & Solvents: Ethyl acetate, Isobutyl benzene, Monochloroacetic acid, Acetyl chloride

Chemicals in the pipeline: Sorbitol and Acetonitrile

Ethyl acetate being green solvent, 2019 global sale valued at $3.3 billion, massive opportunity for scale, Capex ongoing

One can easily guess that #IOLCP is trying to establish a whole supply chain (backward & forward integration) of products by looking at their current product portfolio

This can lead to Value addition and margin expansion

One chemical commodity is transformed into another

Examples, where they are filling the gaps, are

Ethanol+Acetic acid = Ethyl acetate
Acetic acid → Acetyl chloride
Acetic acid → Monochloroacetic Acid
Acetic acid+ammonia = acetamide → Acetonitrile

This we can call as Acetic acid cluster

It will be amazing if they make most of the KSM and solvents inhouse for their other APIs

For Ibuprofen manufacturing, inhouse products are

Isobutyl benzene, Acetyl chloride, Monochloroacetic Acid & Acetic acid

Everything!

No other competitor has such capability